Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$0.11 - $0.83 $1,212 - $9,145
-11,019 Reduced 69.87%
4,752 $0
Q3 2022

Nov 09, 2022

SELL
$1.27 - $3.39 $2,143 - $5,722
-1,688 Reduced 9.67%
15,771 $17,000
Q2 2022

Aug 11, 2022

BUY
$1.44 - $3.94 $864 - $2,364
600 Added 3.56%
17,459 $32,000
Q1 2022

May 12, 2022

BUY
$2.86 - $8.83 $36,482 - $112,635
12,756 Added 310.89%
16,859 $60,000
Q4 2021

Feb 11, 2022

BUY
$4.94 - $8.94 $20,268 - $36,680
4,103 New
4,103 $35,000
Q3 2021

Nov 12, 2021

SELL
$6.05 - $10.81 $12,614 - $22,538
-2,085 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$4.56 - $11.45 $9,507 - $23,873
2,085 New
2,085 $14,000

Others Institutions Holding LHDX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Lucira Health, Inc.


  • Ticker LHDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,106,500
  • Market Cap $1.2M
  • Description
  • Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...
More about LHDX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.